BRIDGET MARTELL, M.A. M.D.

Corporate Board Profile

Tech Score: 0/100

DELCATH SYSTEMS, INC.

Filing Date	Source Excerpt
2025-04-01	Bridget Martell, M.A. M.D. was appointed to Delcath Systems’ Board of Directors in May 2024. She brings a wealth of experience from her roles in senior management and as a director at multiple biotechnology companies. The current members of the Audit Committee are Ms. Czerepak (Chair), Mr. Salamon and Dr. Martell. The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Martell and Mr. Sylvester, each of whom is “independent,” within the meaning of the Nasdaq listing rules.

Filing Date

Source Excerpt

2025-04-01

Bridget Martell, M.A. M.D. was appointed to Delcath Systems’ Board of Directors in May 2024. She brings a wealth of experience from her roles in senior management and as a director at multiple biotechnology companies. The current members of the Audit Committee are Ms. Czerepak (Chair), Mr. Salamon and Dr. Martell. The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Martell and Mr. Sylvester, each of whom is “independent,” within the meaning of the Nasdaq listing rules.

Data sourced from SEC filings. Last updated: 2025-12-06